Skip to main content

Struggling with Constantly Being Emotionally Unstable?

Explore Borderline Personality Disorder Clinical Trials investigating potential treatment options!

Borderline Personality Disorder (BPD) is a mental health disorder characterized by a pattern of unstable emotions, relationships, self-image, and impulsive behavior. People with BPD frequently have intense and rapid mood swings, difficulty regulating their emotions, and persistent fear of abandonment. The disorder affects about 1-2% of the general population.

Revive Research Institute is conducting clinical research investigating novel BPD treatment options that may help manage symptoms.

You may qualify for Borderline Personality Disorder Clinical Trials if you:

  • Are 18 to 65 years of age
  • Have been diagnosed with BPD 3 months prior to the screening test
  • Have a BMI < 35kg/m2

*Take part in this paid bipolar disorder clinical trial at no cost to you or your private medical insurance. You will be reimbursed financially for your time and travel. In addition, all participants receive study-related treatment from Doctors and Healthcare experts.

*Take part in this Borderline Personality Disorder research study at no cost to you or your private medical insurance. You will be reimbursed financially for your time and travel. In addition, all participants get free study-related treatment from Doctors and Healthcare experts.

*If you are interested in participating in the Borderline Personality Disorder Clinical Trials or would like more information, please fill out the form so we can determine if you qualify for the study and contact you. Note that this is an entirely voluntary decision. If you change your mind about participating in a study, you can leave at any time.

Please provide YOUR contact information only.
Borderline Personality Disorder Clinical Trials flyer

About the Borderline Personality Disorder Research Study

BPD is a common psychiatric disorder that affects about 1-2% of the general population. We are conducting Borderline Personality Disorder Clinical Trials to assess the safety and efficacy of an oral drug in the adult population. Participants in this Borderline Personality Disorder Research Study will be given a study treatment as an adjuvant to standard treatment if they have not responded to their current therapy regime.

The study drug will be administered to approximately 200 men and women. Borderline Personality Disorder Clinical Trials will be conducted in a number of locations across the United States, including our site at Chicago, Illinois. This is a multicenter Phase II Placebo-controlled, Randomized, Double-Blind clinical trial.

The study treatment for participants will last 14 weeks. To ensure study eligibility, all participants must complete a 2-week screening period. Participants who meet the eligibility criteria and choose to participate will be given the option of receiving 12 weeks of double blind active treatment or a placebo. We’re looking into the safety and efficacy of an oral study drug used to treat agitation and aggression in adults with BPD.

*There is no cost to you, your private medical insurance, or the public health insurance plan for study procedures. The study drug, related procedures, and visits will be provided at no charge for the duration of the study.

Get Started: What to Expect?

If you have a borderline personality disorder or an emotionally unstable personality disorder, this study may be for you. This is a phase 2 study evaluating the safety and efficacy of an investigational medication in adults with borderline personality disorder who are no longer responding to traditional treatment.

After completing the online form above, one of our research team members will contact you and call you to determine whether you are a good fit for the Borderline Personality Disorder Clinical Trials. After your eligibility is confirmed, you will be asked to sign an Informed Consent Form (ICF). This will take place during a Screening/Introductory Visit, for which you will be summoned to the clinical site. Following your signature, you will be asked a series of questions about your health and medical history, as well as subjected to a number of tests.

You will formally be a part of Borderline Personality Disorder Research Studies then, which will last around 14 weeks. You will be given the experimental drug or the placebo, which must be taken orally, during this time. The placebo is a drug without the active ingredient. Neither you nor your study doctor will know which drug you receive unless in the case of an adverse event.

*All study-related care is provided free of cost. Complete physical examination and other study-related assessments will be done by expert physicians and health care experts.

Length of study Treatment

14 weeks

Number of study visits

9 study weeks

Location

Chicago, Illinois

About Borderline Personality Disorder

Participate in Borderline Personality Disorder Clinical Trials Today

Borderline personality disorder (BPD) is a mental health disorder characterized by persistent patterns of unstable interpersonal relationships, self-image, and emotions. People with BPD often experience intense emotions, impulsivity, and difficulties in maintaining stable relationships.

Symptoms
Symptoms can range from mild to severe and can include the combination of the following:

  • Unclear or shifting self-image
  • Impulsive, self-destructive behaviors
  • Repeated self-harm or suicidal behavior
  • Extreme emotional swings
  • Chronic feelings of emptiness
  • Explosive anger
  • Fear of abandonment

Causes

The specific cause is yet to be discovered. However, BPD is possibly linked to:

  • Childhood abuse and trauma
  • Genetics
  • Brain changes

Complications

If left untreated for a long time, it might lead to complications like:

  • Depression
  • Alcohol or other substance misuse
  • Anxiety disorders
  • Eating disorders
  • Bipolar disorder
  • Post-traumatic stress disorder (PTSD)
  • Attention-deficit/hyperactivity disorder (ADHD)

It’s important to note that BPD is a complex disorder, and symptoms can vary widely between individuals. Diagnosis and treatment should be conducted by qualified mental health professionals, such as psychiatrists or psychologists.

Frequently Asked Questions (FAQs)

1. How common is borderline personality disorder?

Borderline personality disorder (BPD) is estimated to affect approximately 1-2% of the general population. It is more commonly diagnosed in women than in men, with some studies suggesting that BPD is diagnosed three times more frequently in women. However, it’s important to note that the exact prevalence rates can vary depending on the study and the specific population being studied.

BPD is frequently diagnosed in clinical settings, such as mental health clinics or inpatient facilities, as individuals with BPD often seek treatment for their symptoms. However, it is believed that many individuals with BPD may go undiagnosed or misdiagnosed due to the complexity and overlap of symptoms with other mental health disorders.

2. Who is affected by borderline personality disorder?

Borderline personality disorder (BPD) can affect individuals from various backgrounds, but there are certain factors that may increase the likelihood of developing the disorder. Here are some factors that can play a role:

Gender: BPD is more commonly diagnosed in women than in men, although it can affect individuals of any gender.

Family history: There is evidence to suggest that there may be a genetic component to BPD. Having a close family member, such as a parent or sibling, with BPD or other personality disorders can increase the risk of developing the disorder.

Childhood trauma or adverse experiences: Many individuals with BPD have experienced childhood trauma, such as physical or sexual abuse, neglect, or unstable family environments. Adverse experiences during childhood can contribute to the development of BPD symptoms.

Environmental factors: Growing up in an invalidating or chaotic environment, where emotions are dismissed or not appropriately validated, can contribute to the development of BPD.

Neurobiological factors: Some research suggests that certain brain abnormalities or dysregulation of neurotransmitters, such as serotonin, may play a role in the development of BPD. However, further research is needed to fully understand the neurobiological factors involved.

3. What are the treatments for borderline personality disorder?

People may be able to recover from BPD with correct assistance and treatment. Treatment usually involves some type of psychotherapy for borderline personality disorder and medications.

4. What are the risk factors for borderline personality disorder?

Risk factors for borderline personality disorder (BPD) include genetic predisposition, childhood trauma, an invalidating environment, neurobiological factors, and co-occurring mental health conditions. While these factors increase the likelihood of developing BPD, they don’t guarantee its development. It’s important to seek professional help if you or someone you know exhibits symptoms or has multiple risk factors for BPD.

5. What does borderline personality disorder feel like?

A person with BPD is extremely sensitive to abandonment and being alone, which causes intense feelings of anger, fear, suicidal thoughts and self-harm, and impulsive choices.

Close Menu

Revive Research Institute, Inc.

28270 Franklin Road
Southfield, MI
48034

T: 248-564-1485
E: info@rev-research.com